Reviewed October 31, 2026 · For B2B procurement and development teams

Incoming inspection for injection pen components is a documented acceptance activity applied to a defined lot, specification and sampling plan. AQL is an index used in acceptance-sampling systems; it is not a promise that an accepted shipment contains no defects and it should not be copied from another product without a risk-based decision. ISO 2859-1:2026 provides AQL-indexed sampling schemes for a continuing series of lots and includes normal, tightened, reduced and skip-lot concepts with switching rules. ISO 28590:2017 introduces the wider ISO 2859 series and helps users select an inspection system. Before choosing a sample size, the buyer and supplier should agree on the lot definition, inspection level, defect categories, AQL indexes where applicable, random-selection method, acceptance and rejection rules, handling of critical characteristics and response to a failed lot. Device risk and process capability remain part of the decision.
Scope boundary: This guide explains procurement and quality-planning concepts. It does not prescribe an AQL, sample size, critical-defect rule or release decision for a specific device or market.
Project inputs to control
- Lot definition and supplier process boundary
- Component revision and approved specification
- Random sample-selection method
- Inspection level and sampling-plan version
- Defect categories and acceptance criteria
- Critical characteristics and special controls
- Switching, resubmission and failed-lot rules
- Supplier data, certificates and change history
What does AQL mean for an incoming injection-pen lot?
AQL indexes a sampling scheme for lot acceptance; it does not describe the exact defect percentage inside one accepted shipment.
ISO 2859-1:2026 addresses inspection by attributes for a continuing series of lots. The plan links lot size, inspection level and AQL to a sample-size code and acceptance or rejection numbers. The standard also uses switching rules so inspection severity can respond to the history of submitted lots. A buyer should record the edition used because the 2026 third edition replaced the 1999 edition and its amendments.
Acceptance sampling makes a probabilistic decision from a sample. It creates producer and consumer risks that need to be understood by the responsible quality team. An accepted lot can still contain nonconforming units, and a conforming lot can be rejected by the plan. AQL should therefore sit inside a broader supplier-control system. It cannot replace an adequate specification, capable process, traceability, complaint feedback or special control for a characteristic where a sampling plan does not provide acceptable protection.
Plan identifiers to record
- Standard edition and plan type
- Lot size and inspection level
- AQL index and sample-size code
- Acceptance, rejection and switching rules
How should the lot and random sample be defined?
A useful sampling decision starts with a lot that represents one controlled production and traceability context, followed by a genuinely random selection method.
Define the supplier, manufacturing site, component number, revision, material or colour where relevant, production period and traceability identifier. Avoid combining units from different moulds, cavities, processes or revisions when that mixture prevents meaningful disposition. If the shipment contains several traceable sublots, state whether each is inspected separately or how the plan treats them.
Random selection should reach the full lot, not only cartons nearest the door. Record carton or pallet locations and the method used to select units. A convenience sample can miss clustered defects and does not support the planned statistical decision. Protect samples from damage during withdrawal and preserve their identity through inspection. For destructive or functional tests, define whether sampled units return to stock. If a supplier resubmits a rejected lot after sorting or rework, keep the original disposition, rework record and new lot identity connected rather than treating the shipment as an untouched first submission.
Lot record fields
- Supplier, site and process
- Part number, revision and component lots
- Shipment and production traceability
- Sampling locations and selected-unit identities
How should defect categories and inspection methods be set?
Classify characteristics from device risk and specification impact, then use an inspection method capable of detecting the defined nonconformance.
A cosmetic mark, a dimension that affects cartridge retention and a feature that can prevent dose delivery do not carry the same consequence. Define each nonconformance in observable terms and connect it to the drawing, specification or approved visual standard. Avoid labels such as major or minor without a written example or decision rule. The responsible quality and engineering teams should identify characteristics that need a special control outside a routine AQL plan.
Confirm that gauges, fixtures and visual conditions are suitable. A sample plan cannot correct a measurement system that cannot distinguish conforming from nonconforming parts. Record calibration, resolution, lighting, magnification and operator qualification as applicable. Attribute inspection produces a conforming or nonconforming decision, while variable data can provide different information about process distribution. Choose the method that supports the requirement. Keep destructive tests, functional tests and appearance checks separate when they use different samples or disposition rules.
Characteristic review
- Requirement and defect definition
- Risk and downstream device effect
- Inspection method and measurement capability
- Sample disposition and escalation route
What supplier evidence should accompany incoming inspection?
Incoming inspection should use supplier records and process knowledge without turning a certificate into an automatic release decision.
Request the purchase specification, approved revision, certificate or test record where required, lot traceability and change status. Review whether the supplier's evidence covers the same characteristic and lot as the receiving decision. A generic material declaration or an earlier dimensional report may support supplier qualification but does not establish that the current shipment meets every device requirement.
Use inspection history to manage the relationship. ISO 2859-1:2026 includes switching concepts for a continuing series of lots; apply them through a controlled procedure rather than informal sample reduction. A failed lot needs documented containment, disposition, supplier response and evaluation of units already used. Under FDA's QMSR, finished-device manufacturers need applicable quality-system controls and records. The quality agreement should assign notification, deviation, rework, resubmission and record-retention responsibilities. Reduced inspection does not remove the supplier's duty to meet the specification or the buyer's responsibility for the finished-device decision.
Evidence package
- Approved specification and purchase revision
- Lot-specific supplier records
- Incoming result and disposition
- Corrective action, change and trend history
Evidence review matrix
| Decision layer | Required definition | Common error to avoid |
|---|---|---|
| Lot | Traceable production and shipment boundary | Combining unrelated revisions or process histories |
| Sample | Random selection across the accessible lot | Taking only convenient cartons or top-layer units |
| Characteristic | Observable requirement and capable method | Using vague defect labels without examples |
| Plan | Edition, level, AQL and switching procedure | Treating AQL as the allowed defect rate in one lot |
| Disposition | Acceptance, rejection, rework and resubmission records | Erasing the first rejection after sorting |
Sources and related engineering guides
Use the current official source, its revision status and the controlled project configuration when converting this guide into requirements. Public summaries identify scope; they do not replace the full standard, qualified regulatory review or product-specific evidence.
Primary sources
- ISO 2859-1:2026, AQL-indexed sampling schemes for lot-by-lot inspection
- ISO 28590:2017, Introduction to the ISO 2859 series
- FDA, Quality Management System Regulation
Continue the topic cluster
- Injection pen supplier qualification
- Injection pen design transfer
- Injection pen design changes
- Manufacturing and quality approach
Questions buyers also ask
No. AQL indexes an acceptance-sampling scheme and relates to process-average performance in the system. It is not permission to knowingly ship nonconforming product.
No universal value is appropriate. The responsible team should consider the characteristic, device risk, process knowledge, inspection system and commercial agreement.
No. Acceptance sampling makes a probabilistic lot decision. Supplier controls, process capability, traceability and post-release feedback remain necessary.
A controlled sampling system can include reduced or skip-lot provisions and switching rules. Apply the current standard and the buyer's approved procedure rather than reducing inspection informally.